Bringing the fundamentals into focus…
Back to PROCEPT BioRobotics Corporation
How PROCEPT BioRobotics Corporation stacks up
PRCT · against 462 other Healthcare companies of similar size
Profitability
22/ 100
Near the bottom of its peers.
Ranked #373 of 463 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score42 peers with a profitability score of 20–29, including PRCT · Click a bar to see the companies
Why profitability scores 22?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 89% of peers. Return on invested capital: -55.1% vs peer median 4.7%
- a thinner operating margin: weaker than 81% of peers. Operating margin: -33.9% vs peer median 7.1%
- a lower return on assets: weaker than 67% of peers. Return on assets: -3.0% vs peer median 1.7%
Metric by metric
Position: dot = PRCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 437 reported | -55.1% | 5.0% | 10% | 33% | |
| Operating marginHigher is better · 434 reported | -33.9% | 6.9% | 15% | 33% | |
| Return on assetsHigher is better · 448 reported | -3.0% | 1.7% | 30% | 33% | |
| Return on equityHigher is better · 430 reported | -30.2% | 3.0% | 21% | Context only | |
| Gross marginHigher is better · 482 reported | 63.4% | 47.7% | 69% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around PRCT| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 595M USD | 99 | 97 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 368 | 595M USD | 23 | 29 | |
| 373 | 2.2B USD | 22 | 32 | |
| 373 | 827M USD | 22 | 41 | |
| 373 | 1.6B USD | 22 | 30 | |
| 373 | 1.1B USD | 22 | 46 | |
| 373 | 2.0B USD | 22 | 29 | |
| 378 | 6.8B CNY (≈$947M) | 21 | 27 | |
| 378 | 2.2B USD | 21 | 23 | |
| 380 | 1.8B USD | 20 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score